Advertisement

Topics

Companies Related to "Global Development secures future drug candidate development CollegeHill" [Most Relevant Company Matches] - Page: 5 RSS

11:52 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Global Development secures future drug candidate development CollegeHill" found in our extensive corporate database of over 50,000 company records.

Showing "Global Development secures future drug candidate development CollegeHill" Companies 101–125 of 13,000+

Relevant

FOCUS Clinical Drug Development GmbH

FOCUS is an independent drug development organisation with 120 employees, offering full-service Phase I to III clinical development packages or individual service modules. The headquarters are located in Neuss/Duesseldorf, Germany with affiliates in Heidelberg, Moscow, Tokyo and Jakarta.


Phidea.Inc.

Phidea was founded in Milan in 1982, as a Drug Development Company, and in 1991 the Spanish subsidiary, based in Madrid, started its activities. Since its foundation Phidea has built a broad know how in global product development, starting its involvement after the definition of the chemical entity of the active pharmaceutical ingredient, and bringing it to registration and supporting its commerci...

TD2

Translational Drug Development (TD2) is an oncology development organization that provides innovative services for oncology-focused biopharmaceutical companies. Using a dedicated team of professionals with broad experience and understanding in drug development, TD2 is uniquely positioned to support improved and accelerated development of medicines for life...


Frontage Laboratories, Inc.

Frontage is a rapidly expanding global pharmaceutical research and development services company with facilities in the U.S. and China. Frontage provides a broad range of early drug development services to facilitate pharmaceutical discovery, development, preclinical, clinical research, and regulatory consulting to assist Sponsor companies to resolve comple...

CDRD

The Centre for Drug Research and Development (CDRD) (www.cdrd.ca) provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD combines its drug development platform with a commercial arm, which licenses technologies from affiliate...

Boston Strategics Corporation

BSC is an integrated drug R&D company with experience in developing, managing and optimizing global drug development programs from late discovery, through translational research, first-in-man proof-of-concept studies. Its mission is to continuously improve patient health care by changing the drug R&D paradigm using “True” Open Innovation™ pl...

Progen Pharmaceuticals

Progen Pharmaceuticals Limited (NASDAQ:PGLA; ASX: PGL) is a globally focused biotechnology company committed to improving patient outcomes through discovery and development of small molecule-based cancer therapeutics. The company has an intimate understanding of the role of heparan sulfate, a complex sugar, in cancer disease processes and have developed a small-molecule drug development program i...

pSivida Corp.

pSivida Corp. is a world leader in the development of tiny, sustained release, drug delivery products and technologies that are administered by implantation, insertion or injection. The Company uses these systems to develop treatments for serious, unmet, medical needs. pSivida’s intellectual property portfolio consists of 59 patent families, more than...

Osteologix

Osteologix was formed early in 2003 as Nordic Bone A/S based on venture capital funding from the Scandinavian venture fund Nordic Biotech K/S and proprietary rights associated with the company’s primary development project.At the company’s inception, Dr. Klaus Eldrup Jørgensen assumed the role of CEO. In November 2003 Dr. Stephan Christgau joined the company as COO and acting CEO while Klaus ...

Strategic Name Development, Inc.

Strategic Name Development, Inc., a brand naming company, has expertise in global product naming, company naming, tagline development, and brand architecture. We utilize our global capabilities while combining linguistics, creativity, and brand name research to build global brand names that are instantly recognizable, memorable, tradem...

The Science Advisory Board

The Science Advisory Board (http://www.scienceboard.net) is an international community of tens of thousands of scientific and medical experts. Its mission is to be the catalyst for future scientific and medical breakthroughs. Members of this global network of research, development, and manufacturing professionals showcase their knowledge, share thei...

Aizant Drug Research Solutions (P) Ltd

Aizant is established by individuals with over 30 years of pharmaceutical industrial experience in the USA. Aizant provides comprehensive drug development resources and solutions for Pre-formulation, Formulation Development, Analytical Development, cGMP Scale-up, Stability, Bioavailability, Bioequivalence, Bioanalytical and Diagnostics for regulated and emerging markets.

Ttp Translational Technology

We are a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. We have a pipeline of small molecule clinical and pre-clinical drug candidates for the tr...

Transcept Pharmaceuticals, Inc.

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. The most advanced Transcept product candidate is Intermezzo® (zolpidem tartrate sublingual tablet), for which a New Drug Application (NDA) was submitted to the U.S. Food and Drug Admin...

PPD Incorporated

PPD, Inc. (PPD) is a leading global provider of discovery research and development services for pharmaceutical and biotechnology companies. PPD helps clients maximize return on their R&D investments through innovative technologies and strategic solutions that reduce total drug development time and achieve each client's objectives as if PPD were an extension of the client's organization.

Inte:Ligand

The discovery of suitable lead structures for new drugs from an inexhaustibly large reservoir of theoretically possible compounds (order of magnitude: 10100) is one of the biggest challenges for the pharmaceutical industry. The search for the "needle in the haystack" (a drug candidate) nowadays is often performed by using high throughput screening (HTS), neglecting that even high-throughput method...

Biovertis AG

Biovertis is a privately-held, Austrian biotechnology company focusing on the discovery and development of novel classes of small molecule antibacterials. The antibiotics market is currently dominated by drug classes that have been in use for decades. However, an alarming rise in pathogens that are resistant to these types of drugs has created an urgent, unmet medical need in this field. With an a...

Pharmaceutical Regulatory Services, Inc

Pharmaceutical Regulatory Services, Inc. is a provider of expert clinical and regulatory support of all phases of global drug development. We support clinical and regulatory activities in the USA, European Union, as well as the emerging markets of Asia Pacific, Latin America, and Central and Eastern Europe. This includes regulatory support of: new chemical entity development, clinical trials, m...

PPD and HLT

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 48 countries and more than 21,000 professionals worldwide, PPD appli...

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...

Spirogen Ltd

Spirogen was founded in 2001 as a spin-out from several institutions including University College London.  Since that time, it has developed a novel class of highly potent cytotoxic warheads based on its proprietary pyrrolobenzodiazepines (PBDs), DNA minor groove binding agents, which bind and cross-link specific sites of DNA of the cancer cell.  This blocks the cancer cells’ div...

Catalyst Biosciences, Inc.

Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform rapidly creates and optimizes tailor-made protease drug candidates that cleave a wide variety of disease targets, either by improving existing protease drugs or by creating new protease drugs,...

FlowMetric, Inc.

FlowMetric, Inc. is a nimble and highly-responsive contract research organization (CRO) that provides leading edge flow cytometry techniques, analyses and cell sorting services that combine proprietary assays with advanced analytics to support all stages of drug development and therapeutics for pharmaceutical and biotech companies and research institutions...

OctoPlus N.V.

OctoPlus is a drug product development company that is globally renowned as a center of excellence in formulation development, drug delivery and manufacturing. We offer proven and reliable services in formulation development, analytical development, process development and GMP manufacturing. Our expertise is focused on formulation of biotech-derived compounds and small chemical molecules. In...

PPD and Acurian

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD a...


More From BioPortfolio on "Global Development secures future drug candidate development CollegeHill"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks